Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Celularity (CELU) Total Debt (2022 - 2025)

Celularity (CELU) has disclosed Total Debt for 4 consecutive years, with $4.3 million as the latest value for Q3 2025.

  • On a quarterly basis, Total Debt changed N/A to $4.3 million in Q3 2025 year-over-year; TTM through Sep 2025 was $4.3 million, a N/A change, with the full-year FY2024 number at $38.4 million, up 98.71% from a year prior.
  • Total Debt was $4.3 million for Q3 2025 at Celularity, down from $40.8 million in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $40.8 million in Q2 2025 to a low of $4.3 million in Q3 2025.
  • A 4-year average of $28.2 million and a median of $35.1 million in 2022 define the central range for Total Debt.
  • Peak YoY movement for Total Debt: plummeted 64.32% in 2023, then surged 98.71% in 2024.
  • Celularity's Total Debt stood at $37.6 million in 2022, then plummeted by 48.59% to $19.3 million in 2023, then soared by 98.71% to $38.4 million in 2024, then plummeted by 88.85% to $4.3 million in 2025.
  • Per Business Quant, the three most recent readings for CELU's Total Debt are $4.3 million (Q3 2025), $40.8 million (Q2 2025), and $39.0 million (Q1 2025).